Securities code: Boya Bio-Pharmaceutical Group Co.Ltd(300294) securities abbreviation: Boya Bio-Pharmaceutical Group Co.Ltd(300294) Announcement No.: 2022018 Boya Bio-Pharmaceutical Group Co.Ltd(300294)
Announcement on holding the explanation meeting of 2021 Annual Report
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete without false records, misleading statements or major omissions.
Boya Bio-Pharmaceutical Group Co.Ltd(300294) (hereinafter referred to as "the company") was posted on cninfo.com on March 23, 2022（ http://www.cn.info.com.cn./ ）The full text of the 2021 annual report and the summary of the 2021 annual report were disclosed on the.
In order to facilitate the majority of investors to further understand the company's annual operation in 2021, the company is scheduled to hold an online briefing on the annual performance in 2021 in the small program " Boya Bio-Pharmaceutical Group Co.Ltd(300294) investor relations" from 15:00 to 17:00 on March 25, 2022. The online briefing will be held remotely through the Internet. Investors can log in to the " Boya Bio-Pharmaceutical Group Co.Ltd(300294) investor relations" applet to participate in interactive exchanges.
1. Time: 15:00 ~ 17:00, March 25, 2022
2. Participation mode:
Participation method 1: Search " Boya Bio-Pharmaceutical Group Co.Ltd(300294) investor relations" in wechat;
Participation mode 2: scan the following QR codes through wechat:
According to the prompt, the investor is authorized to log in to the " Boya Bio-Pharmaceutical Group Co.Ltd(300294) investor relations" applet to participate in the exchange. 3. Attendees: Mr. Liang Xiaoming, President, Mr. Liang Huacheng, chief financial officer, Mr. Tu Yanshi, Secretary of the board of directors, Mr. Zhang Weidong, independent director, and Mr. Hu Chaofeng, sponsor representative.
Please participate actively! It is hereby announced.
Boya Bio-Pharmaceutical Group Co.Ltd(300294) board of directors March 22, 2022
